Eastman Q3 2026 slides show margin gains despite estimate miss
Eastman Chemical (EMN) reported Q3 2026 earnings of $1.84/share, missing estimates of $1.94, with revenue at $2.39B, slightly below the $2.41B forecast. Despite this, margins improved, with adjusted EBIT rising to $305M (12.8% margin) from $210M (9.5%) a year ago. The company cited higher selling prices, favorable price-cost dynamics, and cost reduction initiatives as drivers. Segment performance varied, with Additives & Functional Products showing the strongest results.
How this was made
The 30-second read
Why it matters
The earnings miss and guidance cut drove a 2% share decline, highlighting short-term downside risk.
Market read
Fresh earnings data with guidance change provides actionable insight for traders.
What to watch
DOE circular economy award may provide long-term upside despite short-term miss.
Background
Eastman Chemical posted Q3 2026 results with revenue slightly below estimates and adjusted EPS of $1.84 versus $1.94 consensus.
Ticker impact
Eastman Chemical reported Q3 2026 earnings miss and cut full-year cash flow guidance.
likely pressure as market prices in the earnings miss and reduced cash flow outlook
The company missed EPS expectations and cut operating cash flow guidance, prompting a 2% stock decline.
Market effects
Specialty chemicals sector may see broader pressure from earnings miss.
U.S. market may see slight pullback in materials stocks.
Limited to investors tracking chemical manufacturers.
Counterpoint
Margin expansion could support a rebound if raw material costs stabilize.
Key entities
- companyEastman Chemical Company
Specialty chemicals manufacturer reporting Q3 2026 results.



